Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
Titel:
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
Auteur:
Waks, A.G. Cohen, O. Kochupurakkal, B. Kim, D. Dunn, C.E. Buendia Buendia, J. Wander, S. Helvie, K. Lloyd, M.R. Marini, L. Hughes, M.E. Freeman, S.S. Ivy, S.P. Geradts, J. Isakoff, S. LoRusso, P. Adalsteinsson, V.A. Tolaney, S.M. Matulonis, U. Krop, I.E. D’Andrea, A.D. Winer, E.P. Lin, N.U. Shapiro, G.I. Wagle, N.